Optimal Longitudinal Care for Sickle Cell Disease

Novartis Kenya Ltd

Sickle Cell Disease is a group of inherited blood disorders caused by abnormal hemoglobin, leading to various complications. The presentation outlines the burden of SCD, particularly in Uganda, where a significant number of children are affected. It also covers the pathophysiology, acute and chronic complications, and the importance of screening for associated conditions. Additionally, it discusses disease-modifying agents like Hydroxyurea and L-Glutamine, their mechanisms of action, and their efficacy in managing SCD.